STAAR Surgical Terminates Merger Agreement with Alcon

STAAR Surgical announced preliminary results of its Special Meeting of Stockholders, stating that the necessary stockholder votes to approve the merger agreement with Alcon were not received. STAAR intends to terminate the agreement, and the company will remain a standalone, publicly traded entity. STAAR's CEO, Stephen Farrell, expressed commitment to maximizing stockholder value and realizing the full potential of STAAR's innovative technology.